No Deal

genomeweb
360dx

No Deal

Aug 30, 2010

Genzyme rejected Sanofi-Aventis' $18.5 billion buyout offer, the New York Times reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

CareDx Closes $52.8M Common Stock Offering
Mayo Clinic Spinout Phenomix Sciences Launches $1M Seed Funding Round
In Brief This Week: Biocartis, CHOP, Agilent, and More
People in the News: Glenn Miles, Roy Smythe, Steve Ziganti, More
RenalytixAI Raises $29M, Preps for Launch of Kidney Dx
Coffee Consumption Linked to Genetic Markers for Bitter Taste Perception

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

Science in Africa Unevenly Funded

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

Not Enough Progress?

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

This Week in Science

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.

Main menu

No Deal

To read the full story....

Breaking News

CareDx Closes $52.8M Common Stock Offering

Mayo Clinic Spinout Phenomix Sciences Launches $1M Seed Funding Round

In Brief This Week: Biocartis, CHOP, Agilent, and More

People in the News: Glenn Miles, Roy Smythe, Steve Ziganti, More

RenalytixAI Raises $29M, Preps for Launch of Kidney Dx

Coffee Consumption Linked to Genetic Markers for Bitter Taste Perception

The Scan

A Winning Diagnostic

Science in Africa Unevenly Funded

Not Enough Progress?

This Week in Science

Sponsorships